Skip to main content
Premium Trial:

Request an Annual Quote

BioForce Completes $6M Private Placement

NEW YORK, March 21 (GenomeWeb) - BioForce Nanosciences said today it has closed a $6-million private placement of restricted common shares at $1.50 per share.


The financing will be used to help commercialize the NanoArrayer and for "continued development of the company's pipeline technologies," said Eric Henderson, BioForce founder and CEO, in a statement.


As GenomeWeb News reported, BioForce completed a $1.5 million bridge financing round to launch the NanoArrayer in December 2004.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.